Prevention and Management of Ovarian Hyperstimulation Syndrome (OHSS)

- References

1. Golan A, et al. Ovarian hyperstimulation syndrome: an update. Fertil Steril. 1989.

2. Delvigne A, Rozenberg S. Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Hum Reprod Update. 2002.
3. Mathur R, et al. Review of the evidence base strategies to prevent ovarian hyperstimulation syndrome. Hum Fertil (Camb). 2007.
4. Rizk B, Aboulghar M. Modern management of ovarian hyperstimulation syndrome. Hum Reprod. 1991.
5. Soares SR, et al. High ovarian response to controlled ovarian stimulation: how to manage and prevent ovarian hyperstimulation syndrome. Reprod Biomed Online. 2008.
6. Aboulghar MA, Mansour RT. Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures. Hum Reprod Update. 2003.
7. Practice Committee of the American Society for Reproductive Medicine. Ovarian hyperstimulation syndrome. Fertil Steril. 2016.
8. RCOG Green-top Guideline No. 5. The management of ovarian hyperstimulation syndrome. 2016.
9. Lee TH, et al. Risk factors for ovarian hyperstimulation syndrome in Korean women: implications for individualized prevention. J Korean Med Sci. 2010.
10. Papanikolaou EG, et al. An ovarian prediction index to prevent ovarian hyperstimulation syndrome. Reprod Biomed Online. 2006.
11. Tarlatzis BC, et al. Ovulation induction and ovarian hyperstimulation syndrome. Baillieres Clin Obstet Gynaecol. 2000.
12. D'Angelo A, Amso NN. OHSS: pathophysiology and prediction. Hum Fertil (Camb). 2002.
13. Nastri CO, et al. Low dose human chorionic gonadotropin in lieu of luteinizing hormone activity supplementation in IVF cycles: a systematic review and meta-analysis. Hum Reprod Update. 2012.
14. Mathur R, et al. Pregnancy following severe ovarian hyperstimulation syndrome resulting in successful twin live birth: case report. Hum Reprod. 1997.
15. The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004.
16. Al-Inany HG, et al. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. Cochrane Database Syst Rev. 2016.
17. Oudshoorn SC, et al. Individualized versus standard follicle-stimulating hormone dosing in women starting assisted reproductive technology: an open-label, multicentre, randomized, controlled, non-inferiority trial. Lancet. 2017.
18. Tarlatzis BC, et al. Comparison of clomiphene citrate and letrozole for induction of ovulation in women with polycystic ovary syndrome. Fertil Steril. 2007.
19. Humaidan P, et al. GnRH agonist trigger: efficacy and safety. Reprod Biomed Online. 2014.
20. Rienzi L, et al. Luteal support in IVF cycles: the role of progesterone supplementation. Hum Reprod Update. 2011.
21. Broer SL, et al. The use of dopamine agonists in the prevention of OHSS: a systematic review. Reprod Biomed Online. 2012.
22. Gook DA, et al. The role of the freeze-all strategy in preventing OHSS: a systematic review. Fertil Steril. 2016.
23. Shapiro BS, et al. Coasting strategies and their efficacy in reducing the risk of OHSS. J Assist Reprod Genet. 2006.
24. Cakmak H, et al. The use of lower-dose hCG trigger in IVF cycles: effects on OHSS risk. Fertil Steril. 2012.
25. Aydin N, et al. Letrozole in the prevention of OHSS: evidence from clinical studies. Hum Reprod. 2008.
26. Melica G, et al. Efficacy of luteal GnRH antagonists in reducing OHSS risk. J Assist Reprod Genet. 2008.
27. Koster MPH, et al. Aspirin as a preventive measure for OHSS: a systematic review. Fertil Steril. 2015.
28. Biliński J, et al. Metformin and OHSS: an updated review. J Assist Reprod Genet. 2010.
29. Strowitzki T, et al. Effectiveness of mifepristone and other adjunctive medications in preventing OHSS: a meta-analysis. Hum Reprod Update. 2005.
30. Schweder M, et al. The use of volume expanders in OHSS prevention: a systematic review. Reprod Biomed Online. 2013.
31. Serour G. Clinical manifestations of ovarian hyperstimulation syndrome.   Ovarian hyperstimulation syndrome book. Jan Gerris et al., Chapter 4 25:40. 2006
32. National Institute for Health and Care Excellence (NICE) Clinical Guideline [CG156]: Fertility problems: assessment and treatment, 2013.
33. The Practice Committee of the American Society for Reproductive Medicine, "Ovarian hyperstimulation syndrome," Fertility and Sterility, 2016.
34. Prevention of Venous Thromboembolism: British Committee for Standards in Haematology Guidelines, 2010.
35. RCOG Green-top Guideline No. 37a, "Reducing the Risk of Venous Thromboembolism during Pregnancy and the Puerperium," 2015.
36. Critical Care Obstetrics and Gynecology, "Acute Care and Management of Ovarian Hyperstimulation Syndrome," 2019.
37. Society for Assisted Reproductive Technology (SART) and ASRM, "Management of Ovarian Hyperstimulation Syndrome," 2014.
38. ACOG Practice Bulletin No. 131, "Management of Ovarian Hyperstimulation Syndrome," 2015.
39. ACOG Practice Bulletin, "Nausea and vomiting of pregnancy," 2018.
40. Ferraretti AP, et al. "Management of OHSS and guidelines for prevention: International consensus," Fertility and Sterility, 2011.
41. The American Society of Anesthesiologists (ASA) Guidelines, 2018.
42. Royal College of Obstetricians and Gynaecologists (RCOG) Green-top Guideline No. 37a, 2015.
43. Lockwood CJ, et al. "Venous thromboembolism in pregnancy." New England Journal of Medicine, 2017.
44. American College of Obstetricians and Gynecologists (ACOG) Practice Bulletin No. 200: "Management of Ovarian Hyperstimulation Syndrome," 2018.
45. ASRM Practice Committee, "Ovarian Hyperstimulation Syndrome: Review and Guideline," Fertility and Sterility, 2016.